Shengji Yu

1.1k total citations
47 papers, 763 citations indexed

About

Shengji Yu is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Shengji Yu has authored 47 papers receiving a total of 763 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 18 papers in Pulmonary and Respiratory Medicine and 16 papers in Surgery. Recurrent topics in Shengji Yu's work include Sarcoma Diagnosis and Treatment (15 papers), Reconstructive Surgery and Microvascular Techniques (8 papers) and Management of metastatic bone disease (7 papers). Shengji Yu is often cited by papers focused on Sarcoma Diagnosis and Treatment (15 papers), Reconstructive Surgery and Microvascular Techniques (8 papers) and Management of metastatic bone disease (7 papers). Shengji Yu collaborates with scholars based in China, United States and Sweden. Shengji Yu's co-authors include Xiaoyang Li, Jin Yuan, Hai Wang, Guangjun Nie, Yue Yin, Haixia Ma, Di Yu, Jie Zhang, Xiaoyang Li and Libin Xu and has published in prestigious journals such as Advanced Materials, Nano Letters and ACS Nano.

In The Last Decade

Shengji Yu

45 papers receiving 753 citations

Peers

Shengji Yu

ONCOL

IMMUN

SURGE

Lays Martin Sobral Brazil

Arianne M. Brandsma Netherlands

Xiaoli Wei China

Jonathan G. Sham United States

Joonho Shim South Korea

Ammira S. Al-Shabeeb Akil Qatar

Yoonjeong Choi South Korea

Sandra Chapman United States

Kanako Nanbu Japan

Nhan Lu-Chinh Phan Vietnam

Lays Martin Sobral Brazil

Shengji Yu

479 ×1.6

208 ×1.1

ONCOL

60 ×0.4

IMMUN

167 ×1.2

71 ×0.5

SURGE

Citations per year, relative to Shengji Yu Shengji Yu (= 1×) peers Lays Martin Sobral

Countries citing papers authored by Shengji Yu

Since Specialization

Citations

This map shows the geographic impact of Shengji Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shengji Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shengji Yu more than expected).

Fields of papers citing papers by Shengji Yu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shengji Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shengji Yu. The network helps show where Shengji Yu may publish in the future.

Co-authorship network of co-authors of Shengji Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Shengji Yu. A scholar is included among the top collaborators of Shengji Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shengji Yu. Shengji Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ma, Haixia, Xiaoyang Li, Jinxi Li, et al.. (2025). Generation of patient-derived sarcoma organoids for personalized drug screening and precision cancer immunotherapy. Biomaterials. 324. 123546–123546.

Tan, Mixiao, Xiaoyang Li, Guoliang Cao, et al.. (2024). Augmenting Protein Degradation Capacity of PROTAC through Energy Metabolism Regulation and Targeted Drug Delivery. Advanced Materials. 37(1). e2412837–e2412837. 5 indexed citations

Zheng, Xuejing, et al.. (2024). Single-cell transcriptomic insights into chemotherapy-induced remodeling of the osteosarcoma tumor microenvironment. Journal of Cancer Research and Clinical Oncology. 150(7). 356–356. 3 indexed citations

Yuan, Jin, Xiaoyang Li, & Shengji Yu. (2023). Cancer organoid co-culture model system: Novel approach to guide precision medicine. Frontiers in Immunology. 13. 1061388–1061388. 67 indexed citations

Yuan, Jin, Xiaoyang Li, & Shengji Yu. (2023). The efficacy of re-excision after unplanned excision for synovial sarcoma. Heliyon. 10(1). e23437–e23437. 2 indexed citations

Zhang, Shuguang, Kun Chen, Zhenguo Zhao, et al.. (2022). Lower Expression of GBP2 Associated With Less Immune Cell Infiltration and Poor Prognosis in Skin Cutaneous Melanoma (SKCM). Journal of Immunotherapy. 45(6). 274–283. 12 indexed citations

Zhang, Xinxin, et al.. (2022). Can the Unipedicular Approach Replace Bipedicular Percutaneous Balloon Kyphoplasty for the Management of Metastatic Vertebral Lesions?. Academic Radiology. 30(10). 2147–2155. 2 indexed citations

Yu, Shengji, et al.. (2022). Transcription-associated cyclin-dependent kinase 12 (CDK12) as a potential target for cancer therapy. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1878(1). 188842–188842. 10 indexed citations

Li, Xiaoyang, et al.. (2022). Patient-derived Tumour Organoids: A Bridge between Cancer Biology and Personalised Therapy. Acta Biomaterialia. 146. 23–36. 20 indexed citations

10.

Yin, Yue, Wen Su, Jie Zhang, et al.. (2021). Separable Microneedle Patch to Protect and Deliver DNA Nanovaccines Against COVID-19. ACS Nano. 15(9). 14347–14359. 100 indexed citations

11.

Yin, Yue, Xiaoyang Li, Haixia Ma, et al.. (2021). In Situ Transforming RNA Nanovaccines from Polyethylenimine Functionalized Graphene Oxide Hydrogel for Durable Cancer Immunotherapy. Nano Letters. 21(5). 2224–2231. 160 indexed citations

12.

Zhang, Shuguang, et al.. (2021). PMEL as a Prognostic Biomarker and Negatively Associated With Immune Infiltration in Skin Cutaneous Melanoma (SKCM). Journal of Immunotherapy. 44(6). 214–223. 18 indexed citations

13.

Zhang, Shuguang, et al.. (2021). Factors associated with bone metastasis in breast cancer: a systematic review and meta-analysis. Annals of Palliative Medicine. 10(4). 4435–4452. 7 indexed citations

14.

Li, Xiaoyang, et al.. (2021). Comparison of the clinical outcomes of percutaneous kyphoplasty for the management of osteolytic and osteoblastic-related metastatic vertebral lesions. Journal of NeuroInterventional Surgery. 14(9). 938–941. 6 indexed citations

15.

Zhang, Xinxin, et al.. (2021). Analysis of prognostic factors in 171 patients with myxofibrosarcoma of the trunk and extremities: a cohort study. Annals of Translational Medicine. 9(16). 1322–1322. 4 indexed citations

16.

Zhang, Xinxin, Xiying Yu, Zhenguo Zhao, et al.. (2019). MicroRNA-429 inhibits bone metastasis in breast cancer by regulating CrkL and MMP-9. Bone. 130. 115139–115139. 26 indexed citations

17.

Zang, Mengqing, et al.. (2018). Distally based anteromedial thigh flaps pedicled on the rectus femoris branch of the lateral circumflex femoral artery for reconstruction of soft-tissue defect of the knee. Journal of Plastic Reconstructive & Aesthetic Surgery. 71(5). 743–749. 5 indexed citations

18.

Liu, Yuanbo, Qiang Ding, Mengqing Zang, et al.. (2017). Classification and Application of the Distally-Based Thigh Flap Based on the Lateral Circumflex Femoral Artery System. Annals of Plastic Surgery. 78(5). 497–504. 6 indexed citations

19.

Zang, Mengqing, Shengji Yu, Libin Xu, et al.. (2015). Intercostal artery perforator propeller flap for reconstruction of trunk defects following sarcoma resection. Journal of Plastic Reconstructive & Aesthetic Surgery. 68(6). 822–829. 17 indexed citations

20.

Ding, Qiang, et al.. (2013). Nearly total unilateral buttock reconstruction with a proximally pedicled anterolateral thigh flap: A case report. Journal of Plastic Reconstructive & Aesthetic Surgery. 66(6). e166–e168. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact